Heidelberg Pharma Reports Outcome of the Annual General Meeting 2022
Heidelberg Pharma AG announced that the shareholders of the Company approved the resolutions of the administration with large majorities (ranged from 98.49% to 99.99%) during the virtual Annual General Meeting today: